Skip to main content

Rare kidney & urinary condition

ANCA-associated vasculitis and the kidney

ANCA vasculitis inflames the smallest blood vessels, and the kidney is its most dangerous target - untreated it can destroy function within weeks, while modern therapy achieves remission in most patients.

Key points

The essentials at a glance.

What to look out for, how the diagnosis is confirmed, who looks after it, and the options that exist.

  • 01

    Warning picture: fatigue, weight loss, joint aches with blood and protein in urine and rising creatinine - often over weeks.

  • 02

    ANCA blood tests (PR3 and MPO) plus urgent kidney biopsy establish the diagnosis.

  • 03

    Induction: rituximab or cyclophosphamide with glucocorticoids; avacopan now offers a steroid-sparing option.

  • 04

    Plasma exchange is considered in severe kidney failure or lung haemorrhage.

  • 05

    Maintenance rituximab reduces relapse; long-term follow-up tracks ANCA, kidney function and drug effects. Relapses are common and treatable when caught early.

Understanding it

What it is, and what happens next.

In plain English - what is going on, how specialists confirm it, and the routes to treatment in the UK.

In ANCA vasculitis, autoantibodies prime neutrophils to attack vessel walls, and the glomerulus - a knot of capillaries - is exquisitely vulnerable: crescentic inflammation can extinguish filters at a pace few kidney diseases match. The transformation of this disease is one of nephrology's success stories, from untreatable to over 80% remission, but the outcome still pivots on how much kidney is lost before treatment starts.

That makes recognition the rate-limiting step: unexplained kidney impairment with an active urine sediment deserves same-week nephrology assessment and ANCA testing, not routine-queue referral; once confirmed, induction therapy begins promptly, with rituximab increasingly preferred, avacopan trimming steroid exposure, and a structured relapse-surveillance plan for the years after remission.

A quiet reminder

This guide is for information, not medical advice.

Your GP or specialist knows your history and can tell you which parts apply to you. If in doubt, speak to them.

Published 2026-09-27 · Next review 2027-09-27

Frequently asked

Common questions about ANCA-associated vasculitis and the kidney.

Quick, plain-English answers to what people ask us most.

  • How does ANCA-associated vasculitis affect the kidney?

    ANCA-associated vasculitis affects the kidney by causing inflammation of the small blood vessels within the kidney's filtering units, leading to glomerulonephritis, which can rapidly impair kidney function if untreated.

  • What causes ANCA kidney disease?

    It results from ANCA antibodies triggering an inflammatory attack on small blood vessels within the kidney, part of the broader systemic ANCA-associated vasculitis process.

  • What are the symptoms of ANCA kidney disease?

    Symptoms include blood in the urine, foamy urine from protein loss, swelling, and, as kidney function declines, fatigue and other symptoms of kidney impairment; symptoms often occur alongside other features of vasculitis elsewhere in the body.

  • Is ANCA kidney disease dangerous?

    Yes, it can cause rapid, severe kidney damage if untreated, sometimes progressing to kidney failure within weeks, making urgent diagnosis and treatment essential.

  • Can ANCA kidney disease be treated?

    Yes, prompt treatment with immunosuppressive medications can significantly improve outcomes and often preserve or improve kidney function, particularly when started before extensive kidney damage has occurred.

  • How is ANCA kidney disease treated?

    Treatment typically involves urgent immunosuppressive therapy (such as steroids combined with rituximab or cyclophosphamide), sometimes alongside plasma exchange for very severe presentations, followed by longer-term maintenance treatment.

  • How is ANCA kidney disease diagnosed?

    Diagnosis usually involves blood tests for ANCA antibodies, urine tests, and often a kidney biopsy to confirm the pattern and severity of inflammation and guide treatment intensity.

  • ANCA kidney disease vs other causes of glomerulonephritis — what's the difference?

    Many conditions can cause glomerulonephritis, but ANCA kidney disease is specifically associated with positive ANCA antibody blood tests and often accompanied by other features of systemic vasculitis, which helps direct the specific immunosuppressive treatment used.

  • Can kidney function recover with ANCA kidney disease treatment?

    Often yes, particularly with prompt treatment before extensive scarring has occurred, though the degree of recovery depends on how much damage had already happened before treatment began.

  • When should I see a doctor about possible ANCA kidney disease, and how quickly can I be seen privately?

    See a doctor promptly for blood in the urine with other symptoms suggesting vasculitis. NHS nephrology referral for suspected urgent kidney disease is typically expedited, and private specialist assessment is often available within about one to two weeks.